Search

Your search keyword '"Georgios A. Margonis"' showing total 190 results

Search Constraints

Start Over You searched for: Author "Georgios A. Margonis" Remove constraint Author: "Georgios A. Margonis"
190 results on '"Georgios A. Margonis"'

Search Results

1. Accuracy of various criteria for lymph node staging in ductal adenocarcinoma of the pancreatic head by computed tomography and magnetic resonance imaging

2. Liver metastases from pancreatic ductal adenocarcinoma: is there a place for surgery in the modern era?

3. Peptide Signatures for Prognostic Markers of Pancreatic Cancer by MALDI Mass Spectrometry Imaging

4. The R.O.A.D. to precision medicine

5. Somatic Mutations in Surgically Treated Colorectal Liver Metastases: An Overview

6. An interpretable AI model for recurrence prediction after surgery in gastrointestinal stromal tumour: an observational cohort studyResearch in context

9. Gp130 is expressed in pancreatic cancer and can be targeted by the small inhibitor molecule SC144

10. Precision surgery for colorectal liver metastases: Current knowledge and future perspectives

11. Nontumor related risk score: A new tool to improve prediction of prognosis after hepatectomy for colorectal liver metastases

12. Near-infrared Fluorescence Imaging for Detecting Pancreatic Liver Metastasis in an Orthotopic Athymic Mouse Model

13. Impact of myopenia and myosteatosis on postoperative outcome and recurrence in Crohn’s disease

14. Prognostic and Therapeutic Implications of Tumor Biology in Colorectal Liver Metastases

15. Demystifying BRAF Mutation Status in Colorectal Liver Metastases: A Multi-institutional, Collaborative Approach to 6 Open Clinical Questions

16. Performance of the 7th and 8th Editions of the American Joint Committee on Cancer Staging System in Patients with Intraductal Papillary Mucinous Neoplasm-Associated PDAC

17. Survival rates and prognostic factors in right- and left-sided colon cancer stage I–IV: an unselected retrospective single-center trial

20. Is prognosis uniformly excellent in patients with stage II MSI-high colon cancer?

21. Comparison of Hepatic Arterial Infusion Pump Chemotherapy vs Resection for Patients With Multifocal Intrahepatic Cholangiocarcinoma

22. Comment on: KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations

23. Using Artificial Intelligence to Find the Optimal Margin Width in Hepatectomy for Colorectal Cancer Liver Metastases

24. The interplay of KRAS mutational status with tumor laterality in non-metastatic colorectal cancer: An international, multi-institutional study in patients with known KRAS, BRAF, and MSI status

25. Staged or Simultaneous Surgery for Colon or Rectal Cancer with Synchronous Liver Metastases: Implications for Study Design and Clinical Endpoints

26. The optimal cut‐off values for tumor size, number of lesions, and CEA levels in patients with surgically treated colorectal cancer liver metastases: An international, multi‐institutional study

27. Two-Stage Hepatectomy for Bilateral Colorectal Liver Metastases: A Multi-institutional Analysis

28. SC144 - a promising small-molecule gp130-inhibitor of IL-6 and Oncostatin-M signaling for treatment of pancreatic cancer

29. The Interplay Between Innate Immunity (TLR-4) and sCD40L in the Context of an Animal Model of Colitis-associated Cancer

30. Liver metastases from pancreatic ductal adenocarcinoma: is there a place for surgery in the modern era?

31. Colectomy with ileostomy for severe ulcerative colitis-postoperative complications and risk factors

32. Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach?

33. Rethinking the TNM Classification Regarding Direct Lymph Node Invasion in Pancreatic Ductal Adenocarcinoma

34. Prognostic value of primary tumor sidedness in patients with non-metastatic IBD related CRC – Is it the exception to the rule?

35. Is Laterality Prognostic in Resected KRAS-Mutated Colorectal Liver Metastases? A Systematic Review and Meta-Analysis

36. Η μελέτη της αντιοξειδωτικής και αντιφλεγμονώδους δράσης μορίων (U-74389G και σιλδεναφίλης) σε πειραματικό πρότυπο χημικής αιμορραγικής κολίτιδας σε επίμυες

38. Author response to

39. Mutant KRAS as a prognostic biomarker after hepatectomy for rectal cancer metastases: Does the primary disease site matter?

40. The Interplay of Primary Tumor Location and KRAS Mutation Status in Patients with Synchronous Colorectal Cancer Liver Metastases: Current Data and Unanswered Questions

41. Predicting Survival in Colorectal Liver Metastasis: Time for New Approaches

42. KRAS mutational status impacts pathologic response to pre-hepatectomy chemotherapy: a study from the International Genetic Consortium for Liver Metastases

43. The Prognostic Impact of Primary Tumor Site Differs According to the KRAS Mutational Status

44. Prognostic Factors Change Over Time After Hepatectomy for Colorectal Liver Metastases

45. The impact of resection margin on overall survival for patients with colon cancer liver metastasis varied according to the primary cancer location

46. Platelet Depletion/Transfusion as a Lethal Factor in a Colitis-associated Cancer Mouse Model

47. Mutation status and surgical selection

48. Main Duct Dilatation Is the Best Predictor of High-grade Dysplasia or Invasion in Intraductal Papillary Mucinous Neoplasms of the Pancreas

49. Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis

50. Enhanced Recovery After Surgery: Is It Time to Change Our Strategy Regarding Laparoscopic Colectomy?

Catalog

Books, media, physical & digital resources